iBio, Inc. (IBIO)
1.42
-0.01
(-0.70%)
USD |
NASDAQ |
Aug 24, 16:00
1.40
-0.02
(-1.41%)
After-Hours: 20:00
iBio 1 Year Total Returns (Daily) : 79.52% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 79.52% |
| August 21, 2026 | 84.21% |
| August 20, 2026 | 93.50% |
| August 19, 2026 | 103.3% |
| August 18, 2026 | 95.21% |
| August 17, 2026 | 95.63% |
| August 14, 2026 | 110.9% |
| August 13, 2026 | 92.04% |
| August 12, 2026 | 156.5% |
| August 11, 2026 | 150.7% |
| August 10, 2026 | 135.6% |
| August 07, 2026 | 137.2% |
| August 06, 2026 | 133.6% |
| August 05, 2026 | 124.8% |
| August 04, 2026 | 130.5% |
| August 03, 2026 | 115.5% |
| July 31, 2026 | 105.9% |
| July 30, 2026 | 103.8% |
| July 29, 2026 | 97.13% |
| July 28, 2026 | 95.77% |
| July 27, 2026 | 97.79% |
| July 24, 2026 | 93.35% |
| July 23, 2026 | 84.04% |
| July 22, 2026 | 87.60% |
| July 21, 2026 | 94.03% |
| Date | Value |
|---|---|
| July 20, 2026 | 87.41% |
| July 17, 2026 | 89.04% |
| July 16, 2026 | 84.43% |
| July 15, 2026 | 97.27% |
| July 14, 2026 | 88.24% |
| July 13, 2026 | 78.00% |
| July 10, 2026 | 83.03% |
| July 09, 2026 | 80.75% |
| July 08, 2026 | 81.88% |
| July 07, 2026 | 102.7% |
| July 06, 2026 | 118.6% |
| July 02, 2026 | 127.0% |
| July 01, 2026 | 133.4% |
| June 30, 2026 | 129.3% |
| June 29, 2026 | 129.1% |
| June 26, 2026 | 135.2% |
| June 25, 2026 | 117.8% |
| June 24, 2026 | 116.6% |
| June 23, 2026 | 131.6% |
| June 22, 2026 | 125.7% |
| June 18, 2026 | 87.78% |
| June 17, 2026 | 96.37% |
| June 16, 2026 | 77.35% |
| June 15, 2026 | 77.78% |
| June 12, 2026 | 64.08% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Capricor Therapeutics, Inc. | -4.23% |
| Ocugen, Inc. | 34.65% |
| CytomX Therapeutics, Inc. | 55.19% |
| ACADIA Pharmaceuticals, Inc. | 15.19% |
| Alnylam Pharmaceuticals, Inc. | -48.06% |